Lateral flow assays (LFAs), such as the COVID-19 rapid test ... To increase LFA sensitivity and testing capacity, researchers adapted LFA technology so they can detect RNA or DNA instead of proteins.

Enter the anti-CRISPR protein AcrVIB1, a promising inhibitor whose exact function has remained a mystery—until now. A research team from the Helmholtz Institute for RNA-based Infection Research ...